Literature DB >> 30713474

Highlight report: Protection of cholestatic livers by shunting of bile from canaliculi to sinusoids.

Tahany Abbass1, Walaa Murad1, Abdel-Latif Seddek2.   

Abstract

Entities:  

Year:  2018        PMID: 30713474      PMCID: PMC6341458          DOI: 10.17179/excli2018-1738

Source DB:  PubMed          Journal:  EXCLI J        ISSN: 1611-2156            Impact factor:   4.068


× No keyword cloud information.

Cholestatic liver diseases have been reported to show an anatomically ascending course of disease (Jansen et al., 2017[6]). The first lesions occur in downstream bile ducts followed by damage of the upstream liver parenchyma. In the acute phase after obstruction this may lead to a strong increase of bile acids in bile canaliculi up to concentrations that are toxic to hepatocytes. In the recent issue of Hepatology an interesting mechanism has been reported that prevents deterioration of liver tissue in this acute phase of cholestasis (Ghallab et al., 2018[5]). After bile duct ligation in mice bile acid concentrations increase into cytotoxic range of 0.2-2 mM. Between days 1-3 after bile duct ligation the apical hepatocyte membrane ruptures in individual, dispersed hepatocytes. Within minutes the membrane of the same cell also becomes leaky at the sinusoidal/blood side. This creates a shunt between the bile canaliculus and the sinusoidal blood (Ghallab et al., 2018[5]). As a consequence, bile acids leak from overloaded canaliculi into the blood. Therefore, bile acid concentrations in the canaliculi decrease after shunt formation. In principle, the acute cholestatic liver sacrifices some dispersed individual hepatocytes that later can easily be regenerated in order to save the entire organ. Analysis of the mechanisms of hepatotoxicity represents an intensively studied field of research (Fickert et al., 2014[2]; Tag et al., 2015[11]; Stöber, 2016[10]; Ghallab, 2017[3]; Ghallab et al., 2016[4]; Vartak et al., 2016[12]). In recent years procedures of mathematical modeling (Schenk et al., 2017[7]; Sezgin et al., 2018[9]; Bartl et al., 2015[1]; Schliess et al., 2014[8]) and advanced imaging techniques such as combined MALDI and two-photon microscopy as applied in the highlighted study (Ghallab et al, 2018[5]) have contributed to a deeper understanding of the pathomechanisms of liver diseases. Although, the here described mechanism of physical shunting of bile salts from high to low concentration areas protects the liver from more severe damage, it should be considered that this leads to higher concentrations in blood with the long term consequence of kidney damage usually in the form of cholemic nephropathy.

Conflict of interest

There is no conflict of interest.
  12 in total

1.  Optimality in the zonation of ammonia detoxification in rodent liver.

Authors:  Martin Bartl; Michael Pfaff; Ahmed Ghallab; Dominik Driesch; Sebastian G Henkel; Jan G Hengstler; Stefan Schuster; Christoph Kaleta; Rolf Gebhardt; Sebastian Zellmer; Pu Li
Journal:  Arch Toxicol       Date:  2015-10-05       Impact factor: 5.153

Review 2.  Characterization of animal models for primary sclerosing cholangitis (PSC).

Authors:  Peter Fickert; Marion J Pollheimer; Ulrich Beuers; Carolin Lackner; Gideon Hirschfield; Chantal Housset; Verena Keitel; Christoph Schramm; Hanns-Ulrich Marschall; Tom H Karlsen; Espen Melum; Arthur Kaser; Bertus Eksteen; Mario Strazzabosco; Michael Manns; Michael Trauner
Journal:  J Hepatol       Date:  2014-02-19       Impact factor: 25.083

Review 3.  The ascending pathophysiology of cholestatic liver disease.

Authors:  Peter L M Jansen; Ahmed Ghallab; Nachiket Vartak; Raymond Reif; Frank G Schaap; Jochen Hampe; Jan G Hengstler
Journal:  Hepatology       Date:  2017-02       Impact factor: 17.425

4.  Integrated metabolic spatial-temporal model for the prediction of ammonia detoxification during liver damage and regeneration.

Authors:  Freimut Schliess; Stefan Hoehme; Sebastian G Henkel; Ahmed Ghallab; Dominik Driesch; Jan Böttger; Reinhard Guthke; Michael Pfaff; Jan G Hengstler; Rolf Gebhardt; Dieter Häussinger; Dirk Drasdo; Sebastian Zellmer
Journal:  Hepatology       Date:  2014-05-12       Impact factor: 17.425

5.  Model-guided identification of a therapeutic strategy to reduce hyperammonemia in liver diseases.

Authors:  Ahmed Ghallab; Géraldine Cellière; Sebastian G Henkel; Dominik Driesch; Stefan Hoehme; Ute Hofmann; Sebastian Zellmer; Patricio Godoy; Agapios Sachinidis; Meinolf Blaszkewicz; Raymond Reif; Rosemarie Marchan; Lars Kuepfer; Dieter Häussinger; Dirk Drasdo; Rolf Gebhardt; Jan G Hengstler
Journal:  J Hepatol       Date:  2015-11-27       Impact factor: 25.083

6.  Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis.

Authors:  Carmen G Tag; Sibille Sauer-Lehnen; Sabine Weiskirchen; Erawan Borkham-Kamphorst; René H Tolba; Frank Tacke; Ralf Weiskirchen
Journal:  J Vis Exp       Date:  2015-02-10       Impact factor: 1.355

7.  Physiologically-based modelling in mice suggests an aggravated loss of clearance capacity after toxic liver damage.

Authors:  Arne Schenk; Ahmed Ghallab; Ute Hofmann; Reham Hassan; Michael Schwarz; Andreas Schuppert; Lars Ole Schwen; Albert Braeuning; Donato Teutonico; Jan G Hengstler; Lars Kuepfer
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

8.  Pathophysiology of cholestatic liver disease and its relevance for in vitro tests of hepatotoxicity.

Authors:  Regina Stöber
Journal:  EXCLI J       Date:  2016-12-23       Impact factor: 4.068

9.  Cholestasis-induced adaptive remodeling of interlobular bile ducts.

Authors:  Nachiket Vartak; Amruta Damle-Vartak; Beate Richter; Olaf Dirsch; Uta Dahmen; Seddik Hammad; Jan G Hengstler
Journal:  Hepatology       Date:  2016-01-14       Impact factor: 17.425

10.  Highlight report: Metabolomics in hepatotoxicity testing.

Authors:  Ahmed Ghallab
Journal:  EXCLI J       Date:  2017-12-21       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.